MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of MOTS-C is not established in humans. This means dosing 2-3 times weekly is typical to maintain stable levels. The half-life directly affects how long MOTS-C remains active and influences optimal injection timing.
What Is the Half-Life of MOTS-C?
The half-life of MOTS-C is not established in humans. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer MOTS-C to maintain therapeutic blood levels.
What Does MOTS-C's Half-Life Mean for Dosing?
With a half-life of not established in humans, MOTS-C requires dosing 2-3 times weekly to maintain stable levels. The standard dosage of 5-10 mg per week via subcutaneous injection accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, MOTS-C reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For MOTS-C, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject MOTS-C?
Optimal timing depends on your research goals. A half-life of not established in humans means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (2-3 times weekly) for more stable levels throughout the day.
How Does MOTS-C's Half-Life Compare to Similar Peptides?
MOTS-C is a Mitochondrial-derived peptide, metabolic regulator. Its half-life of not established in humans positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your MOTS-C Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.
Open Calculator →Bottom Line: MOTS-C Half-Life and Dosing
MOTS-C has a half-life of not established in humans, supporting the standard protocol of 5-10 mg per week dosed 2-3 times weekly over 8-12 weeks with 8-12 week breaks.
Read our MOTS-C dosage guide for complete protocol details.
Complete Guide
MOTS-c: The Metabolic Mitochondrial Peptide
Related Reading
- MOTS-C Dosage Guide
- MOTS-C Benefits
- MOTS-C Side Effects
- MOTS-C Stacking Guide
- MOTS-C Cycle Guide
- MOTS-C Research
Research-Grade Sourcing
If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What is the recommended MOTS-C dosage?
Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Is MOTS-C safe?
MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.